SCHEMBL14007207

SCHEMBL14007207

CCn1cc(C(=O)NC(C)C)ccc1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.47
BRD4 O60885 3/20 0.47
BRD2 P25440 2/20 0.47
BRD3 Q15059 2/20 0.47
BRDT Q58F21 2/20 0.47
ALDH1A1 P00352 3/20 0.44
MAPT P10636 3/20 0.44
LMNA P02545 2/20 0.44
CYP1A2 P05177 1/20 0.44
ALOX15 P16050 1/20 0.44
CYP2C19 P33261 1/20 0.44
PTGS2 P35354 1/20 0.44
EPHX2 P34913 2/20 0.44
KDM4E B2RXH2 2/20 0.42
HTT P42858 2/20 0.42
GAA P10253 2/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
B3GNT2 Q9NY97 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14007199 0.85 BRD4 (0.45) MLYCDBRD4BRD2BRD3BRDT
SCHEMBL13702154 0.85 BRD4 (0.45) MLYCDBRD4BRD2BRD3BRDT
SCHEMBL14007191 0.84 ALDH1A1 (0.49) MLYCDBRD4BRD2BRD3BRDT
SCHEMBL13702146 0.83 KDM4E (0.44) BRD4BRD2BRD3BRDTALDH1A1
SCHEMBL13702123 0.83 EPHX2 (0.64) MLYCDBRD4BRD2BRD3BRDT
SCHEMBL13702165 0.82 BRD4 (0.49) MLYCDBRD4BRD2BRD3BRDT
SCHEMBL13702181 0.81 LMNA (0.43) MLYCDBRD4BRD2BRD3BRDT
SCHEMBL13702152 0.81 BRD4 (0.73) BRD4BRD2BRD3BRDTALDH1A1
SCHEMBL13702178 0.81 HRH3 (0.51) BRD4BRD2BRD3BRDTALDH1A1
SCHEMBL13702175 0.81 EPHX2 (0.45) MLYCDBRD4BRD2BRD3BRDT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080280904-A1 N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors ELDRUP ANNE BETTINA 2008-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280904-A1 N-Substituted Pyridinone or Pyrimidinone Compounds Useful as Soluble Epoxide Hydrolase Inhibitors EPHX1, EPHX2, DOHH MLYCD 3655/4885BRD4 2988/4885BRD2 3385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.